Evidence map›Paper›PMID 34516241›Full record

ArticleAntimicrobial agents and chemotherapy2021

The Antimicrobial Peptide MK58911-NH

Junya de Lacorte Singulani, Lariane Teodoro Oliveira, Marina Dorisse Ramos, Nathália Ferreira Fregonezi, Paulo César Gomes, Mariana Cristina Galeane, Mario Sergio Palma, Ana Marisa Fusco Almeida, Maria José Soares Mendes Giannini

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Repositioning Antimicrobial Peptides Against WHO-Priority Fungi.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Junya de Lacorte SingulaniDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University-UNESP, Araraquara, Brazil.
Lariane Teodoro OliveiraDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University-UNESP, Araraquara, Brazil.
Marina Dorisse RamosDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University-UNESP, Araraquara, Brazil.
Nathália Ferreira FregoneziDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University-UNESP, Araraquara, Brazil.
Paulo César GomesDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University-UNESP, Araraquara, Brazil.
Mariana Cristina GaleaneDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University-UNESP, Araraquara, Brazil.
Mario Sergio PalmaDepartment of Basic and Applied Biology, Institute of Biosciences, São Paulo State University-UNESP, Rio Claro, Brazil.
Ana Marisa Fusco AlmeidaDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University-UNESP, Araraquara, Brazil.
Maria José Soares Mendes GianniniDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University-UNESP, Araraquara, Brazil.ORCID 0000-0002-8059-0826
Universidade Estadual Paulista (Unesp) · BR

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 2017/06658-9MCTI | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
6 · The paper itself

Abstract

Cryptococcosis is associated with high rates of morbidity and mortality, especially in AIDS patients. Its treatment is carried out by combining amphotericin B and azoles or flucytosine, which causes unavoidable toxicity issues in the host. Thus, the urgency in obtaining new antifungals drives the search for antimicrobial peptides (AMPs). This study aimed to extend the understanding of the mechanism of action of an AMP analog from wasp peptide toxins, MK58911-NH

Indexed as

Cryptococcus neoformansAnimalsAntifungal AgentsAntimicrobial PeptidesBiofilmsCryptococcosisHumansMacrophagesMicrobial Sensitivity TestsZebrafishAntifungal AgentsAntimicrobial Peptidesantifungal activityantifungal agentsantimicrobial peptidebiofilmcryptococcosisCryptococcus neoformansintramacrophage activitymechanisms of actionnonconventional animal modelssystemic fungisystemic mycoses

Identifiers

PMID34516241
PMCPMC8597745
OpenAlexW3200790559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.